✦ LIBER ✦

2210 – A phase II randomized, double-blind, placebo-controlled trial of GLYX-13 for the rapid treatment of major depressive disorder using central ratings

✍ Scribed by Popp, D.; Burch, R.; Williams, J.B.W.; Price, L.M.; Detke, M.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.b.027 A phase II randomized, double-

✍ Popp, D.; Burch, R.; Williams, J.B.W.; Price, L.M.; Detke, M.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

A randomized, double-blind, placebo-cont

✍ Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Gol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A double-blind, placebo-controlled, mult

✍ Frye, M.A.; Ketter, T.A.; Yang, R.; Calabrese, J.R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Efficacy and tolerability of the novel t

✍ Pierre Tran; Phil Skolnick; Pal Czobor; N.Y. Huang; Mark Bradshaw; Anthony McKin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 297 KB

A double-blind, placebo-controlled treat

✍ Renerio Fraguas; Renata Martinho da Silva Telles; Tânia Correa Toledo Ferraz Alv 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Efficacy and safety of duloxetine for tr

✍ I. Jon Russell; Philip J. Mease; Timothy R. Smith; Daniel K. Kajdasz; Madelaine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 608 KB